Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$1.4M
1 round on record
Latest round
$1.4M
Venture round · Jan 2026 · 9 mo ago
Team
11-50
employees, estimated range
Revenue
$1M
2025 · SEC Form D 0002107494-26-000001
The money's age
Fresh money
9 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2025 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jan 2026 $1.4M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity DeepCyte ApS its site
Founders and leadersfrom filings, registers and the company's site
Theodore AlexandrovExecutive OfficerSEC Form D

Overview

DeepCyte combines single cell metabolomics with AI models to detect drug toxicity early. Reveal why cells turn toxic before drugs reach patients.

People

Theodore Alexandrov
Executive Officer
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Wilmington United States
HQ
10-50 est. staff

Financials

Est. Annual Revenue
$500k
2025
Total raised
$1.4M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 $1.4M Details